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110a Sunday, February 8, 2015in addition to its significantly higher S/B ratio. It requires minimal amount of
organic-anion transporter inhibitor (such as probenecid) in its assay system.
In conclusion, Cal-590 AM is a greatly improved red fluorescent indicator
for measuring intracellular calcium change. The red-shifted wavelength makes
Cal-590 AM a robust tool for evaluating GPCR and calcium channel targets,
multiplexing analysis of cellular functions with a green fluorescent dye as
well as screening agonists and antagonists with GFP cells.
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The STIM-Orai activating region (SOAR) of STIM1 is the minimal sequence
necessary for Orai1 channel activation. Our previous work revealed that
replacement of Phe-394 in SOAR with the dimensionally similar but polar his-
tidine head group prevents Orai1 binding and gating. In the current study, we
constructed YFP-SOAR-SOAR concatemers with a 21 amino acid linker
between the SOAR units which allowed folding into functional dimers. We
introduced the F394H mutation (FH) into either the first (N-terminal) or second
(C-terminal) SOAR unit within the dimeric concatemer constructs. We found
that each of these single-mutated concatemers was able to both bind to Orai1
and gate the Orai1 channel normally, the same as the wild-type concatemer.
In contrast, a concatemer in which both SOAR units contained the F394H
mutation (YFP-SOARFH-SOARFH), was devoid of Orai1 binding and gating
activity. To ensure that the single mutated concatemers were not forming
inter-concatemer dimers, we equally co-expressed the CFP-SOARWT-
SOARWT and YFP-SOARFH-SOARFH concatemeric constructs in the same
cell. While the CFP-SOARWT-SOARWT bound to and activated Orai1, it did
not pull the YFP-SOARFH-SOARFH with it. Thus, the latter remained in the
cytosol in these cells. This result is in contrast to co-expression of the mono-
meric CFP-SOARWT with YFP-SOARFH constructs. In this case, while the
YFP-SOARFH expressed alone does not bind to or activate Orai1, the CFP-
SOARWT clearly dimerizes with YFP-SOARFHmutant and pulls it to the PM.
This also proves that he F394H mutation does not prevent SOAR-SOAR dimer
formation. Overall, the results reveal a surprising new facet of the STIM1-
Orai1 coupling interaction. Thus, although the SOAR dimer is likely the func-
tional Orai1-actiavting unit, only one of the SOAR units within the SOAR
dimer needs to be able bind to and activate the Orai1 channel.
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Receptor-stimulated Ca2þ influx, a critical component of the Ca2þ signal, is
mediated in part by Orai1, which is activated by STIM1 in response to Ca2þ
release from the ER. Orai1 then undergoes slow Ca2þ-dependent inactivation
(SCDI) that is mediated by binding of SARAF to STIM1. We use SCDI by
SARAF as reporter of the conformation and microdomain localization of the
Orai1-STIM1 complex. Interaction of STIM1 with the C terminus of Orai1
and the STIM1 K-domain are required for interaction of SARAF with
STIM1 and Orai1 SCDI. Interaction of SARAF with STIM1 required the pres-
ence of STIM1-Orai1 in a PM/ER microdomain that is tethered by E-Syt1, sta-
bilized by Septin4 and enriched in PI(4,5)P2. Notably, selective targeting of
STIM1 to PI(4,5)P2-rich or to PI(4,5)P2-poor microdomains revealed that
SCDI by SARAF is observed only when the STIM1-Orai1 complex is within
the PI(4,5)P2-rich microdomain. Most notably, measuring the dynamics of
STIM1-Orai1 complex localization in live cells using PI(4,5)P2-rich or
PI(4,5)P2-poor microdomain probes revealed that store depletion is followed
by transient STIM1-Orai1 complex formation in the PI(4,5)P2-poor microdo-
main where the channel is fully active, which then translocates to the PI(4,5)
P2-rich domain to recruit SARAF and initiates SCDI. These findings reveal
the role of the PM/ER tethers in the regulation of Orai1 function and Ca2þ
influx and describe a new mode of regulation by PI(4,5)P2 involving transloca-
tion between PI(4,5)P2 microdomains, rather than by PI(4,5)P2 synthesis and
breakdown.Cardiac Smooth and Skeletal Muscle
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Atrial fibrillation (AF) contributes significantly to cardiovascular morbidity and
mortality. The growing epidemic is associated with cardiac repolarization abnor-
malities and requires the development ofmore effectiveantiarrhythmic strategies.
Cardiac two-pore-domain Kþ channels repolarize action potentials and represent
potential targets for AF therapy. However, electropharmacology ofK2P channels
remains to be investigated in detail. This study was designed to elucidate human
K2P channel regulation by antiarrhythmic drugs vernakalant and flecainde.
Two-electrode voltage clamp and whole-cell patch clamp electrophysiology
was used to record K2P currents from Xenopus oocytes and Chinese hamster
ovary (CHO) cells. The class III antiarrhythmic compound vernakalant acti-
vated K2P17.1 currents in oocytes and in mammalian cells (EC50,CHO ¼
40 mM) in frequency-dependent fashion. K2P17.1 open rectification character-
istics and current-voltage relationships were not affected by vernakalant. In
contrast to K2P17.1, vernakalant reduced K2P4.1 and K2P10.1 currents, in
line with K2P2.1 blockade reported earlier. The class I drug flecainide did
not significantly modulate K2P currents.
In conclusion, vernakalant activates K2P17.1 background potassium channels.
Pharmacologic K2P channel activation may be employed for personalized
rhythm control in patients with AF-associated reduction of Kþ channel function.
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The emergence of human induced pluripotent stem (hiPS) cell technology has
expanded the possibilities for sourcing human cardiomyocytes (hiPS-CMs).
Novel microscopy and analysis methods serve to accelerate development and
validation of in vitro hiPS-CM models for drug screening. Voltage sensitive
dyes (VSD) allow non-invasive, non-destructive, and longitudinal assessment
of hiPS-CM electrophysiology at the sub-cellular membrane scale. In this
study, we successfully use 2-photon microscopy to capture VSD signal at the
cellular membrane scale generated from actively beating hiPS-CMs exposed
to the chronotropic drugs, propranolol (105 M) and isoproterenol (107 M).
We use SimFCS software, developed at the Laboratory for Fluorescence Dy-
namics at the University of California, Irvine, to remove motion artifact and
assess the resultant signal over time. We are able to generate a waveform of
VSD fluorescence that is representative of the changing membrane potential
(i.e. the depolarization of an action potential). A number of characteristics of
these waveforms are defined (upslope, maximum height, plateau height, down-
slope, peak width, and beat rate), compared across treatments, and shown to be
significantly different between treatments. A supervised machine learning algo-
rithm is then trained, validated, and the algorithm accuracy quantified using
these data along with their known drug treatments. The algorithm that results
can be used to predict which drugs hiPS-CMs have been exposed to given
only their respective VSD waveforms. This study tests the hypothesis that
VSDs may be used in conjunction with supervised learning to train an algo-
rithm that is capable of automatically and accurately assessing, classifying,
and predicting the membrane depolarization effects of chronotropic drugs.
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Introduction: The proarrhythmic effects of quinolone antibiotics used clini-
cally have been assessed by measuring the IKr antagonist potency. However,
the gaps between clinically reported proarrhythmic effects and IKr antagonist
